Today's Information |
Provided by: SYNMOSA BIOPHARMA CORPORATION | |||||
SEQ_NO | 1 | Date of announcement | 2022/07/05 | Time of announcement | 11:29:00 |
Subject | Clarification of Commercial Times news reports | ||||
Date of events | 2022/07/05 | To which item it meets | paragraph 53 | ||
Statement | 1.Date of occurrence of the event:2022/07/05 2.Company name:SYNMOSA BIOPHARMA CORPORATION 3.Relationship to the Company (please enter "head office" or "subsidiaries"):head office 4.Reciprocal shareholding ratios:NA 5.Name of the reporting media: Commercial Times, Edition B04, July 5, 2022 6.Content of the report: ............SYNMOSA (4114) Subsidiarie Upright Healthcare Inc. announced on the 4th that it has acquired Shunli Health. Shunli's operating base is concentrated in New Taipei City, with 17 stores, and it is estimated that it will contribute about 300 to 350 million in revenue this year. 7.Cause of occurrence:Media Reports 8.Countermeasures: The company strictly follows the norms of information disclosure, and cannot publish the reported revenue target. Comments, the above reports are estimated by the legal person and the media. The company has not released financial forecasts. For the company's business and financial information, please refer to the announcement of the public information observatory, which is hereby clarified. 9.Any other matters that need to be specified:NONE |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Synmosa Biopharma Corporation published this content on 05 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 July 2022 03:42:01 UTC.